-- MediSwitch Drug Interactions Import (Part 50/112)
INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(22113, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(22113, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(30758, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(30758, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(30758, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(30758, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(30758, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(13800, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(13800, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(13800, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(13800, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(13800, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(33533, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(33533, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(33533, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(33533, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(10244, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(10244, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(10244, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(10244, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(10244, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(22191, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(22191, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(22191, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(22191, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(22191, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(1049, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(1049, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(1049, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(1049, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(29498, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(29498, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(29498, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(29498, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(30699, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(30699, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(30699, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(30699, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(30699, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(33361, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(33361, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(33361, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(33361, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(4793, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(4793, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(4793, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(4793, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(4793, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(30703, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(30703, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(30703, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(30703, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(30703, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(31842, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(31842, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(31842, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(31842, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(31842, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(30538, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(30538, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(30538, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(30538, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(30538, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(23927, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(23927, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(23927, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(23927, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(31260, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(31260, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(31260, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(25226, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(25226, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(29109, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(29109, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(29109, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(29109, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(29109, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(10299, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(10299, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(10299, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(10299, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(32080, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(32080, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(32080, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(32080, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(32080, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(12153, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(12153, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(12153, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(6570, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(6570, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(6570, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(6570, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(6570, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(13396, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(13396, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(13396, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(13396, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(13396, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(30138, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(30138, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(30138, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(30138, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(18963, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(18963, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(26508, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(26508, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(26508, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(26508, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(26508, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(7567, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(7567, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(7567, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(7567, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(5907, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(5907, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(1938, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(1938, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(24983, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(24983, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(24983, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(24983, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(24983, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(27072, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(27072, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(27072, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(27072, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(27072, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(31587, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(31587, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(31587, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(31587, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(31587, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(523, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(523, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(523, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(523, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(523, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(2115, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(2115, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(2115, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(2115, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(2115, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(16643, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(16643, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(16643, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(16643, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(16643, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(6269, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(6269, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(3069, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(3069, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(3069, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(3069, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(3069, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(18499, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(18499, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(18499, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(18499, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(18499, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(13040, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(13040, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(13040, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(13040, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(13040, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(20965, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(20965, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(2461, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(2461, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(2461, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(2461, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(2461, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(13612, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(13612, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(13612, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(13612, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(13612, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(10059, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(10059, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(2371, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(2371, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(2371, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(2371, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(2371, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(30832, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(30832, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(30832, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(30832, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(30832, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(9227, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(9227, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(9227, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(9227, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(9227, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(23329, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(23329, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(23329, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(23329, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(23329, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(10124, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(10124, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(10124, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(10124, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(10124, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(11822, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(11822, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(11822, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(11822, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(11822, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(19017, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(19017, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(19017, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(19017, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(19017, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(883, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(883, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(5184, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(5184, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(5184, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(5184, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(6551, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(6551, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(6551, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(6551, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(2495, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(2495, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(2495, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(2495, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(2495, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(20612, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(20612, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(20612, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(20612, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(20612, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(30079, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(30079, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(30079, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(30079, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(30079, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(15961, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(15961, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(15961, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(15961, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(15961, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(30945, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(30945, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(30945, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(30945, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(30945, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(31184, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(31184, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(31184, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(31184, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(31184, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(6559, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(6559, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(6559, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(6559, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(8394, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(8394, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(8394, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(8394, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(8394, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(15387, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(15387, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(15387, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(15387, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(15387, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(3110, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(3110, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(3110, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(3110, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(15935, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(15935, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(15935, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(19460, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(19460, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(19460, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(19460, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(19460, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(31841, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(31841, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(31841, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(31841, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(31841, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(23212, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(23212, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(23212, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(23212, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(23212, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(20533, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(20533, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(20533, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(20533, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(16631, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(16631, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(16631, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(16631, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(16631, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(5526, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(5526, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(5526, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(5526, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(5526, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(18779, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(18779, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(21690, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(21690, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(21690, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(21690, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(22045, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(22045, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(22045, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(11934, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(11934, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(11934, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(11934, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(11934, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(999, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(999, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(999, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(999, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(999, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(33359, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(33359, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(33359, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(33359, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(25056, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(25056, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(25056, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(25056, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(25056, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(21577, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(21577, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(21577, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(21577, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(21577, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(7343, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(7343, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(7343, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(7343, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(7343, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(3539, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(3539, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(3539, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(3539, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(12864, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(12864, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(12864, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(12864, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(3041, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(3041, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(3041, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(3041, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(3041, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(20015, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(20015, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(20015, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(20015, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(20015, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(29045, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(29045, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(29045, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(29045, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(29045, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(30162, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(30162, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(30162, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(30162, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(30162, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(1664, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(1664, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(1664, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(19795, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(19795, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(19795, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(19795, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(19795, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(4560, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(4560, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(26521, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(26521, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(26521, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(26521, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(26521, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(20342, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(20342, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(20342, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(20342, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(25705, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(25705, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(25705, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(15922, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(15922, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(15922, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(15922, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(15922, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(6342, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(6342, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(6342, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(6342, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(4736, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(4736, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(4736, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(4736, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(4736, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(29684, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(29684, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(29684, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(29684, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(29684, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(21526, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(21526, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(21526, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(21526, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(21526, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(19020, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(19020, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(19020, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(19020, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(17904, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(17904, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(17904, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(17904, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(17904, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(8359, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(8359, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(8359, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(8359, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(8359, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(14453, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(14453, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(14453, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(14453, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(14453, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(19253, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(19253, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(19253, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(31541, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(31541, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(31541, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(31541, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(19788, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(19788, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(19788, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(19788, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(24394, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(24394, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(24394, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(24394, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(24394, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(33038, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(33038, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(29359, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(29359, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(32109, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(32109, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(32109, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(32109, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(12636, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(12636, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(12636, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(12636, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(3227, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(3227, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(3227, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(3227, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(1904, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(1904, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(1904, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(1904, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(1904, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(15478, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(15478, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(15478, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(15478, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(15478, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(4922, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(4922, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(4922, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(4922, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(4922, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(1128, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(1128, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(31496, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(31496, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(31496, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(31496, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(31496, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(20700, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(20700, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(20700, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(20700, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(20700, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(23763, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(23763, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(23763, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(23763, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(23763, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(32679, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(32679, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(32679, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(32679, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(15728, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(15728, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(24212, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(24212, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(24212, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(24212, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(24212, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(3802, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(3802, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(3802, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(3802, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(33551, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(33551, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(6417, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(6417, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(6417, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(6417, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(33544, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(33544, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(33544, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(33544, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(33544, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(4572, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(4572, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(4572, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(4572, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(346, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(346, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(346, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(346, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(27071, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(27071, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(27071, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(27071, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(27071, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(5809, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(5809, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(5809, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(22804, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(22804, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(22804, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(22804, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(22804, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(8848, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(8848, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(8848, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(8848, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(8848, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(4186, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(4186, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(4186, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(4186, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(9970, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(9970, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(9970, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(9970, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(9970, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(30298, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(30298, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(4539, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(4539, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(4539, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(4539, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(4539, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(2904, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(2904, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(1497, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(1497, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(1497, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(1497, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(1497, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(26510, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(26510, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(26510, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(26510, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(33512, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(33512, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(33512, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(33512, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(33512, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(1521, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(1521, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(1521, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(1521, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(31477, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(31477, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(31477, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(31477, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(31477, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(26313, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(26313, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(26313, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(26313, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(26313, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(5942, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(5942, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(5942, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(5942, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(5942, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(22531, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(22531, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(22531, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(22531, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(22531, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(17247, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(17247, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(17247, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(17247, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(17247, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(5992, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(5992, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(5992, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(5992, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(5992, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(29544, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(29544, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(29544, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(29544, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(29544, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(33209, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(33209, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(23593, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(23593, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(15667, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(15667, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(15667, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(15667, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(15667, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(14092, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(14092, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(14092, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(14092, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(14092, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(32095, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(32095, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(32095, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(32095, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(32095, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(6211, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(6211, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(6211, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(6211, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(6211, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(28661, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(28661, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(28661, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(28661, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(28661, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(16173, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(16173, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(11305, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(11305, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(11305, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(11305, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(11305, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(3234, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(3234, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(3234, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(3234, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(6330, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(6330, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(6330, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(6330, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(6330, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(9541, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(9541, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(9541, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(9541, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(9541, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(32201, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(32201, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(32201, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(32201, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(32201, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(28784, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(28784, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(28784, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(28784, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(28784, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(24361, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(24361, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(139, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(139, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(139, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(139, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(29495, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(29495, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(29495, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(29495, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(29495, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(2123, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(2123, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(2123, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(2123, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(2123, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(3121, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(3121, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(3121, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(3121, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(3121, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(3067, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(3067, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(3067, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(3067, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(3067, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(33335, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(33335, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(33335, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(33335, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(33079, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(33079, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(33079, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(33079, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(33079, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(30912, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(30912, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(30912, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(30912, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(30912, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(32062, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(32062, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(32062, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(32062, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(32062, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(17815, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(17815, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(17815, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(17815, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(17815, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(5779, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(5779, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(5779, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(5779, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(5779, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(8510, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(8510, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(8510, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(8510, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(3205, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(3205, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(3205, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(3205, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(3205, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(30896, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(30896, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(30896, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(30896, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(30896, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(22114, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(22114, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(22114, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(22114, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(22114, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(31057, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(31057, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(15071, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(15071, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(15071, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(15071, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(15071, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(24608, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(24608, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(24608, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(24608, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(24608, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(2008, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(2008, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(31506, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(31506, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(32193, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(32193, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(32193, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(32193, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(32193, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(32338, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(32338, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(32338, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(32338, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(32338, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(31214, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(31214, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(32606, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(32606, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(30910, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(30910, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(30910, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(30910, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(10302, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(10302, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(10302, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(10302, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(10302, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(30734, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(30734, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(30734, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(30734, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(30734, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(15906, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(15906, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(15906, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(15906, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(6289, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(6289, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(6289, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(6289, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(6289, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(22274, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(22274, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(22274, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(22274, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(22274, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(19193, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(19193, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(19193, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(19193, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(19193, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(16990, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(16990, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(16990, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(16990, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(8402, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(8402, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(8402, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(8402, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(8402, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(16509, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(16509, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(28505, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(28505, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(28505, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(28505, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(32180, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(32180, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(32180, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(32180, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(32180, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(24369, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(24369, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(24369, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(24369, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(918, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(918, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(918, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(918, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(1006, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(1006, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(1006, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(1006, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(1006, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(6358, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(6358, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(6358, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(6358, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(32752, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(32752, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(32752, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(32752, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(33508, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(33508, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(33508, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(33508, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(33508, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(14884, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(14884, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(14884, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(3473, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(3473, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(3473, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(15784, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(15784, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(15784, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(15784, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(15784, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(3799, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(3799, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(3799, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(3799, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(3799, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(1917, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(1917, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(1917, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(1917, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(1917, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(28635, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(28635, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(28635, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(28635, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(28635, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(29631, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(29631, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(29631, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(29631, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(29631, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(27910, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(27910, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(27910, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(27910, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(27910, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(2004, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(2004, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(2004, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(26399, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(26399, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(26399, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(26399, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(26399, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(6484, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(6484, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(6484, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(6484, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(6484, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(31895, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(31895, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(31895, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(31895, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(2466, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(2466, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(2466, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(2466, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(2466, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(33491, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(33491, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(33491, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(33491, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(33491, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(23400, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(23400, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(23400, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(23400, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(23400, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(2377, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(2377, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(2377, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(2377, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(17244, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(17244, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(17244, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(17244, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(17244, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(28270, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(28270, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(28270, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(28270, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(28270, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(757, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(757, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(757, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(757, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(757, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(30078, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(30078, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(30078, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(30078, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(30078, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(26890, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(26890, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(26890, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(26890, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(26890, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(25499, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(25499, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(25499, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(25499, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(25499, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(1155, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(1155, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(1155, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(1155, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(1155, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(30755, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(30755, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(30755, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(30755, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(30755, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(29483, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(29483, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(29483, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(1557, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(1557, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(1557, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(1557, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(15469, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(15469, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(15469, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(15469, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(15469, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(32168, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(32168, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(32168, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(16908, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(16908, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(16908, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(16908, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(16908, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(27211, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(27211, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(27211, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(27211, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(27211, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(5617, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(5617, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(5617, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(5617, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(5617, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(8336, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(8336, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(8336, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(16928, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(16928, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(16928, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(16928, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(16928, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(10101, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(10101, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(10101, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(10101, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(13154, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(13154, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(13154, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(13154, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(14881, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(14881, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(14881, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(14881, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(14881, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(28045, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(28045, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(28045, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(28045, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(32627, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(32627, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(32627, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(32627, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(3263, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(3263, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(3263, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(3263, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(3263, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(33552, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(33552, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(33552, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(8533, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(8533, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(8533, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(8533, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(8533, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(673, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(673, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(19691, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(19691, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(19691, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(19691, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(19691, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(17835, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(17835, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(17835, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(17835, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(17835, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(32510, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(32510, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(32510, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(32510, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(27472, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(27472, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(27472, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(27472, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(27472, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(27602, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(27602, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(27602, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(27602, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(27602, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(23676, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(23676, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(23676, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(23676, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(16642, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(16642, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(16642, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(16642, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(26338, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(26338, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(22137, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(22137, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(22137, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(22137, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(22137, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(32099, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(32099, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(32099, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(32099, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(32099, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(16211, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(16211, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(16211, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(16211, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(16211, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(325, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(325, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(325, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(325, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(12427, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(12427, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(12427, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(263, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(263, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(263, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(263, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(263, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(26770, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(26770, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(26770, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(26770, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(26770, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(13316, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(13316, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(13316, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(13316, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(21171, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(21171, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(21171, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(21171, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(21171, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(4844, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(4844, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(4844, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(4844, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(4844, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(31999, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(31999, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(31999, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(31999, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(31999, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(13439, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(13439, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(13439, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(13439, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(20264, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(20264, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(20264, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(20264, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(20264, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(30892, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(30892, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(30892, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(30892, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(30892, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(25207, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(25207, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(25207, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(25207, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(25207, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(27386, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(27386, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(27386, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(6533, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(6533, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(6533, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(2032, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(2032, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(2032, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(2032, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(2032, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(1156, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(1156, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(1156, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(1156, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(1156, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(21163, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(21163, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(21163, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(21163, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(21163, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(27654, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(27654, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(27654, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(27654, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(27654, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(15783, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(15783, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(15783, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(15783, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(15783, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(5193, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(5193, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(5193, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(5193, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(5193, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(22912, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(22912, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(22912, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(22912, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(22912, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(5587, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(5587, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(5587, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(5587, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(5587, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(8028, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(8028, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(8028, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(8028, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(26899, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(26899, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(26899, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(26899, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(26899, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(2544, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(2544, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(2544, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(2544, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(2544, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(21418, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(21418, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(21418, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(21418, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(21418, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(16482, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(16482, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(16482, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(16482, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(16482, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(16214, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(16214, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(16214, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(16214, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(16214, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(3897, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(3897, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(22889, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(22889, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(22889, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(19692, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(19692, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(19692, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(19692, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(19692, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(32847, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(32847, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(32847, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(26769, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(26769, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(26769, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(26769, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(26769, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(8040, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(8040, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(8040, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(8040, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(8040, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(28891, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(28891, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(28891, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(28891, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(15720, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(15720, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(15720, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(15720, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(33661, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(33661, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(33661, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(28571, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(28571, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(15774, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(15774, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(5454, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(5454, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(5454, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(5454, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(5454, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(18141, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(18141, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(18141, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(18141, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(18141, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(1013, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(1013, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(11034, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(11034, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(11034, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(20815, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(20815, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(20815, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(20815, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(20815, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(7642, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(7642, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(7642, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(7642, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(26282, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(26282, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(26282, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(26282, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(26282, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(23625, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(23625, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(23625, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(23625, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(23625, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(2158, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(2158, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(2158, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(2158, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(2158, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(14086, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(14086, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(14086, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(14086, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(14086, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(7873, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(7873, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(7873, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(7873, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(7873, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(31418, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(31418, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(31418, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(31418, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(31418, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(32664, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(32664, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(32664, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(32664, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(32664, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(21453, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(21453, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(21453, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(21453, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(21453, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(22960, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(22960, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(22960, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(22960, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(22960, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(18650, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(18650, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(18650, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(18650, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(18650, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(13730, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(13730, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(13730, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(13730, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(13730, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(19776, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(19776, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(19776, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(19776, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(19776, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(32905, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(32905, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(32905, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(32905, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(32905, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(27464, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(27464, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(27464, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(27464, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(27464, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(30182, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(30182, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(30182, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(30182, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(23106, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(23106, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(23106, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(23106, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(23106, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(7209, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(7209, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(7209, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(7209, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(31043, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(31043, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(31043, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(22868, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(22868, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(22868, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(22868, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(22868, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(18652, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(18652, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(18652, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(18652, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(18652, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(18000, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(18000, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(18000, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(18000, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(18000, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(26630, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(26630, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(26630, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(26630, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(26630, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(6328, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(6328, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(6328, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(6328, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(6328, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(4685, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(4685, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(4685, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(4685, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(4685, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(1361, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(1361, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(1361, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(1361, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(1361, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(29455, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(29455, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(29455, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(29455, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(29455, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(30376, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(30376, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(30376, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(30376, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(30376, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(29497, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(29497, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(29497, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(29497, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(29497, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(20763, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(20763, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(20763, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(20763, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(20763, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(30505, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(30505, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(30505, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(30505, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(12906, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(12906, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(12906, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(12906, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(31346, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(31346, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(31346, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(4987, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(4987, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(4987, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(4987, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(4987, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(33029, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(33029, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(33029, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(33029, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(33029, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(21257, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(21257, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(21257, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(21257, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(21257, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(2463, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(2463, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(2463, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(2463, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(2463, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(17081, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(17081, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(17081, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(17081, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(17081, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(18672, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(18672, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(18672, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(18672, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(18672, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(3043, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(3043, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(3043, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(13331, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(13331, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(13331, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(13331, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(15594, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(15594, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(15594, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(15594, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(15594, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(5146, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(5146, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(5146, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(5146, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(5146, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(5941, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(5941, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(5941, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(5941, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(5941, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(22450, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(22450, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(22450, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(22450, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(22450, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(20816, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(20816, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(20816, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(20816, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(20816, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(12833, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(12833, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(12833, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(12833, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(14837, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(14837, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(14837, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(14837, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(14837, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(29496, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(29496, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(29496, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(29496, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(29496, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(28660, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(28660, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(28660, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(28660, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(28660, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(7638, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(7638, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(7638, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(7638, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(33005, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(33005, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(33005, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(33005, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(33005, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(6035, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(6035, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(6035, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(6035, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(6035, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(31489, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(31489, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(31489, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(32327, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(32327, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(5870, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(5870, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(5870, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(5870, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(5870, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(6590, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(6590, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(6590, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(6590, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(6590, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(3714, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(3714, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(3714, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(3714, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(3714, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(29658, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(29658, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(29658, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(29658, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(29658, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(31672, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(31672, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(31672, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(31672, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(31672, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(2841, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(2841, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(1511, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(1511, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(1511, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(1511, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(1511, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(33741, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(33741, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(33741, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(33741, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(5527, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(5527, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(5527, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(5527, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(17897, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(17897, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(17897, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(17897, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(17897, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(33033, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(33033, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(33033, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(33033, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(33033, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(28783, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(28783, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(28783, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(28783, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(28783, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(1228, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(1228, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(1228, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(1228, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(1228, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(31040, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(31040, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(31040, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(31040, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(4693, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(4693, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(4693, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(4693, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(4693, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(20971, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(20971, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(20971, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(20971, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(20971, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(24614, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(24614, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(24614, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(24614, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(24614, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(6007, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(6007, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(6007, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(6007, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(17221, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(17221, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(17221, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(17221, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(17221, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(15993, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(15993, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(15993, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(15993, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(15993, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(14487, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(14487, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(14487, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(14487, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(14487, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(23199, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(23199, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(23199, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(23199, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(23199, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(20339, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(20339, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(20339, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(20339, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(13350, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(13350, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(13350, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(13350, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(13350, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(29162, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(29162, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(29162, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(29162, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(29162, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(20972, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(20972, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(20972, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(20972, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(20972, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(28186, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(28186, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(28186, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(28186, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(28186, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(30540, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(30540, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(30540, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(30540, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(30540, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(15320, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(15320, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(15320, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(15320, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(15320, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(1520, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(1520, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(1520, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(1520, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(1520, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(15264, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(15264, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(15264, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(15264, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(15264, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(12127, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(12127, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(12127, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(2926, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(2926, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(2926, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(2926, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(28782, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(28782, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(28782, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(28782, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(28782, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(15601, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(15601, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(15601, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(15601, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(15601, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(12977, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(12977, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(12977, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(12977, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(26924, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(26924, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(26924, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(8395, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(8395, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(8395, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(8395, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(8395, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(33872, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(33872, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(33872, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(33872, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(33872, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(26351, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(26351, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(26351, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(26351, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(4585, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(4585, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(4585, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(4585, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(4585, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(28049, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(28049, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(28049, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(28049, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(28049, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(4820, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(4820, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(4820, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(4820, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(7438, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(7438, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(7438, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(7438, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(7438, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(21778, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(21778, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(21778, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(21778, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(21778, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(3106, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(3106, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(3106, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(21536, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(21536, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(21536, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(21536, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(3276, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(3276, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(3276, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(3276, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(4290, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(4290, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(4290, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(4290, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(4290, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(10110, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(10110, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(10110, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(10110, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(10110, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(32329, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(32329, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(32329, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(32329, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(32329, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(9149, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(9149, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(9149, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(9149, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(33908, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(33908, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(33908, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(33908, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(33908, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(2829, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(2829, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(23712, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(23712, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(25209, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(25209, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(25209, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(25209, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(25209, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(27474, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(27474, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(27474, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(27474, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(27474, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(33810, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(33810, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(33810, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(33810, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(33810, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(21190, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(21190, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(21190, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(21190, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(21190, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(30184, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(30184, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(30184, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(30184, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(30184, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(1425, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(1425, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(1425, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(1425, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(1425, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(29499, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(29499, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(29499, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(29499, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(29499, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(29572, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(29572, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(29572, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(29572, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(29572, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(5331, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(5331, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(5331, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(5331, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(5331, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(31056, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(31056, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(31056, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(31056, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(7935, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(7935, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(7935, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(7935, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(7935, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(15359, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(15359, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(15359, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(15359, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(15359, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(27481, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(27481, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(23928, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(23928, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(23928, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(23928, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(29468, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(29468, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(29468, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(29468, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(29468, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(22119, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(22119, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(22119, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(22119, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(22119, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(15024, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(15024, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(15024, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(15024, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(15024, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(9873, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(9873, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(9873, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(9873, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(20534, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(20534, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(20534, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(20534, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(6174, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(6174, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(6174, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(6174, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(6174, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(6713, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(6713, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(6713, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(6713, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(6713, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(12397, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(12397, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(12397, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(12397, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(12397, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(30689, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(30689, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(30689, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(30689, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(30689, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(787, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(787, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(18987, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(18987, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(18987, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(31957, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(31957, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(31957, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(31957, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(31957, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(5726, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(5726, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(5726, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(5726, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(16982, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(16982, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(16982, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(16982, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(16982, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(17898, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(17898, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(17898, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(17898, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(17898, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(16730, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(16730, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(16730, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(16730, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(16730, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(21183, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(21183, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(21183, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(21183, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(21183, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(3586, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(3586, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(3586, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(18140, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(18140, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(18140, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(18140, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(18140, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(32044, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(32044, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(32044, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(14945, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(14945, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(14945, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(14945, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(14945, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(15945, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(15945, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(15945, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(15945, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(15945, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(30793, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(30793, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(30793, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(30793, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(30793, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(28166, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(28166, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(28166, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(28166, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(28166, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(21586, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(21586, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(21586, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(21586, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(32897, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(32897, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(32897, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(32897, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(32897, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(3915, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(3915, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(3915, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(3915, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(33002, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(33002, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(33002, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(14962, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(14962, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(14962, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(14962, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(14962, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(2968, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(2968, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(2968, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(2968, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(32969, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(32969, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(32969, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(32969, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(32969, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(3162, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(3162, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(3162, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(3162, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(123, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(123, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(123, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(123, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(123, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(20482, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(20482, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(20482, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(20482, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(6337, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(6337, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(6157, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(6157, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(6157, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(6157, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(32192, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(32192, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(32192, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(32192, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(32192, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(23246, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(23246, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(23246, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(23246, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(23246, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(32309, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(32309, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(32309, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(32309, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(32309, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(4477, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(4477, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(2754, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(2754, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(2754, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(21044, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(21044, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(21044, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(21044, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(21044, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(14456, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(14456, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(14456, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(14456, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(14456, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(30584, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(30584, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(30584, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(33215, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(33215, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(33215, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(33215, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(33215, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(19009, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(19009, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(25948, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(25948, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(25948, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(25948, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(25948, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(6895, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(6895, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(6895, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(6895, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(6895, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(30537, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(30537, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(30537, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(30537, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(30537, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(31773, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(31773, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(31773, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(31773, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(32898, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(32898, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(32898, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(32898, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(32898, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(27497, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(27497, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(27497, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(6198, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(6198, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(29466, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(29466, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(29466, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(32112, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(32112, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(32112, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(32112, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(32112, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(30139, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(30139, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(30139, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(30139, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(10109, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(10109, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(10109, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(10109, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(10109, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(16641, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(16641, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(16641, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(16641, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(16641, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(14617, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(14617, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(14617, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(14617, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(14617, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(14646, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(14646, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(14646, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(14646, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(14646, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(20846, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(20846, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(20846, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(32136, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(32136, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(32136, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(32136, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(31475, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(31475, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(31475, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(31475, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(31475, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(25724, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(25724, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(25724, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(25724, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(8190, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(8190, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(8190, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(8190, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(6972, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(6972, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(6972, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(6972, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(6972, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(30157, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(30157, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(30157, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(30157, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(33349, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(33349, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(33349, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(33349, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(33349, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(21538, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(21538, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(21538, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(21538, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(21538, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(4737, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(4737, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(4737, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(4737, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(4737, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(25744, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(25744, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(25744, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(25744, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(25744, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(8213, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(8213, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(8213, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(8213, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(13598, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(13598, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(13598, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(13598, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(13598, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(21525, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(21525, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(21525, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(21525, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(21525, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(2465, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(2465, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(2465, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(2465, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(2465, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(4503, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(4503, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(4503, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(4503, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(4503, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(18712, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(18712, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(18712, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(18712, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(18712, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(29657, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(29657, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(29657, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(29657, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(29657, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(15436, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(15436, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(15436, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(15436, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(1414, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(1414, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(1414, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(14455, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(14455, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(14455, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(14455, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(14455, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(18212, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(18212, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(18212, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(18212, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(18212, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(6734, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(6734, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(6734, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(6734, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(15623, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(15623, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(15623, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(15623, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(15623, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(20609, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(20609, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(20609, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(20609, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(20609, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(33324, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(33324, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(33324, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(33324, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(33324, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(30158, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(30158, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(30158, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(30158, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(31787, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(31787, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(31787, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(31787, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(31787, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(30607, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(30607, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(30607, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(30607, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(30607, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(7943, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(7943, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(7943, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(7943, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(4839, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(4839, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(26405, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(26405, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(26405, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(26405, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(26405, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(30961, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(30961, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(30961, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(30961, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(30961, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(32923, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(32923, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(32923, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(32923, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(32923, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(28662, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(28662, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(28662, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(28662, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(28662, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(13941, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(13941, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(13941, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(13941, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(8826, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(8826, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(8826, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(30029, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(30029, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(30029, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(30029, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(30029, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(17896, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(17896, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(17896, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(17896, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(17896, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(21160, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(21160, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(21160, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(21160, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(21160, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(32061, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(32061, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(32061, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(32061, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(32061, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(22061, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(22061, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(22061, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(22061, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(22061, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(20784, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(20784, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(20784, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(10946, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(10946, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(10946, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(10946, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(10946, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(18187, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(18187, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(18187, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(18187, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(18187, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(17758, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(17758, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(17758, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(17758, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(31746, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(31746, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(31746, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(28553, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(28553, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(28553, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(28553, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(31455, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(31455, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(16576, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(16576, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(16576, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(16576, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(16576, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(24941, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(24941, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(24941, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(24941, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(24941, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(21689, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(21689, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(21689, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(21689, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(4750, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(4750, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(4750, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(4750, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(1622, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(1622, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(1622, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(1622, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(33244, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(33244, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(33244, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(33244, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(33244, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(33685, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(33685, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(33685, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(33685, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(33685, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(7163, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(7163, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(7163, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(7163, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(7163, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(8259, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(8259, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(8259, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(8259, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(8259, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(24250, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(24250, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(24250, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(24250, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(24250, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(2878, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(2878, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(2878, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(2878, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(2878, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(20976, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(20976, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(24247, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(24247, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(24247, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(24247, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(24247, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(20937, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(20937, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(20937, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(20937, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(20937, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(6300, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(6300, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(6300, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(6300, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(6300, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(15536, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(15536, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(15536, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(15536, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(15536, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(31831, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(31831, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(31831, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(31831, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(31831, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(625, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(625, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(625, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(625, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(625, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(1345, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(1345, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(1345, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(1345, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(1345, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(6177, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(6177, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(6177, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(6177, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(26727, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(26727, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(26727, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(26727, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(26727, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(14339, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(14339, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(14339, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(14339, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(14339, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(3941, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(3941, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(3941, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(13151, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(13151, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(13151, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(13151, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(13151, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(18218, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(18218, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(18218, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(18218, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(18218, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(5787, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(5787, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(5787, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(5787, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(1051, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(1051, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(1051, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(1051, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(1051, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(31627, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(31627, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(31627, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(31627, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(31627, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(31397, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(31397, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(31397, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(31397, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(31397, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(5027, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(5027, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(5027, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(5027, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(13611, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(13611, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(13611, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(13611, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(13611, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(26533, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(26533, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(26533, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(26533, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(29993, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(29993, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(29993, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(29993, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(29993, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(22160, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(22160, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(22160, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(22160, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(32065, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(32065, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(32065, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(32065, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(32065, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(20057, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(20057, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(20057, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(20057, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(20057, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(29454, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(29454, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(29454, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(29454, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(29454, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(7050, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(7050, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(7050, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(7050, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(7050, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(5141, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(5141, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(5141, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(5141, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(5141, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(6155, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(6155, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(6155, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(6155, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(19959, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(19959, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(19959, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(19959, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(19959, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(14523, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(14523, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(14523, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(14523, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(14523, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(5329, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(5329, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(5329, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(5329, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(31126, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(31126, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(31126, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(14008, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(14008, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(14008, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(14008, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(14008, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(17903, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(17903, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(17903, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(17903, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(17903, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(966, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(966, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(966, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(966, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(9482, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(9482, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(9482, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(9482, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(9482, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(8189, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(8189, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(8189, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(8189, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(16216, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(16216, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(16216, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(16216, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(16216, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(28272, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(28272, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(28272, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(28272, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(28272, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(15040, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(15040, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(15040, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(15040, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(15040, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(31332, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(31332, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(31332, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(31332, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(28664, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(28664, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(28664, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(28664, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(28664, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(4631, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(4631, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(4631, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(4631, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(4631, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(14439, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(14439, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(14439, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(14439, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(14439, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(32233, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(32233, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(32233, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(32233, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(32233, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(32339, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(32339, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(10301, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(10301, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(10301, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(10301, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(10301, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(9489, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(9489, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(9489, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(9489, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(2348, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(2348, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(2348, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(2348, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(2348, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(28913, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(28913, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(28913, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(28913, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(28913, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(4159, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(4159, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(4159, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(4159, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(4159, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(20966, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(20966, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(21260, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(21260, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(21260, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(21260, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(21260, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(1981, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(1981, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(27942, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(27942, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(27942, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(27942, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(6012, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(6012, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(6012, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(6012, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(15662, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(15662, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(15662, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(15662, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(15662, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(1042, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(1042, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(1042, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(1042, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(1042, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(26161, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(26161, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(26161, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(26161, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(26161, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(33529, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(33529, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(33529, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(33529, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(5738, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(5738, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(5738, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(5738, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(5738, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(32108, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(32108, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(32108, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(32108, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(32108, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(19345, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(19345, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(19345, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(19345, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(23052, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(23052, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(23052, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(23052, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(4169, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(4169, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(4169, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(21186, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(21186, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(21186, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(21186, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(21186, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(22102, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(22102, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(22102, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(22102, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(22102, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(24343, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(24343, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(13364, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(13364, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(13364, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(13364, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(20025, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(20025, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(20025, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(20025, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(20025, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(6359, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(6359, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(4222, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(4222, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(4222, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(4222, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(4222, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(22974, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(22974, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(22974, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(22974, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(22974, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(33007, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(33007, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(33007, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(33007, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(33007, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(12657, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(12657, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(12657, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(12657, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(12657, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(28889, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(28889, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(6799, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(6799, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(6799, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(6799, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(6799, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(22007, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(22007, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(22007, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(22007, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(22007, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(16729, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(16729, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(16729, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(16729, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(16729, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(3888, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(3888, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(3888, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(3888, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(3888, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(15132, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(15132, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(15132, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(15132, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(19780, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(19780, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(19780, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(19780, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(19780, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(8208, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(8208, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(8208, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(8208, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(8208, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(324, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(324, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(324, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(324, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(324, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(13261, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(13261, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(13261, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(13261, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(31648, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(31648, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(31648, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(31648, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(31648, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(7212, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(7212, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(7212, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(7212, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(7212, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(13940, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(13940, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(13940, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(13940, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(20717, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(20717, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(20717, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(20717, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(20717, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(15537, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(15537, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(15537, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(15537, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(15537, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(31265, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(31265, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(31265, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(31265, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(27311, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(27311, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(8399, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(8399, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(8399, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(8399, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(8399, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(19642, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(19642, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(19642, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(19642, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(19642, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(7844, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(7844, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(7844, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(7844, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(7844, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(15628, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(15628, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(15628, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(15628, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(15628, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(15629, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(15629, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(15629, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(15629, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(15629, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(33131, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(33131, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(33131, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(33131, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(1868, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(1868, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(1868, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(1868, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(1868, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(28163, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(28163, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(28163, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(28163, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(28163, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(8025, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(8025, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(8025, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(8025, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(21158, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(21158, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(21158, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(21158, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(21158, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(18580, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(18580, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(18580, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(18580, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(18580, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(4638, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(4638, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(25877, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(25877, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(25877, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(25877, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(25877, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(5422, 'warfarin sodium', 'N/A', 'minor', 'Alcohol†aminoglutethimideamobarbitalatorvastatin†azathioprinebutabarbitalbutalbitalcarbamazepinechloral hydrate†chlordiazepoxidechlorthalidone cholestyramine†clozapinecorticotropincortisonecyclophosphamide†dicloxacillinethchlorvynolglutethimidegriseofulvinhaloperidolmeprobamate 6-mercaptopurinemethimazole†moricizine hydrochloride†nafcillinparaldehydepentobarbitalphenobarbitalphenytoin†pravastatin†prednisone†primidone propylthiouracil†raloxifeneranitidine†rifampinsecobarbitalspironolactonesucralfatetrazodonevitamin C (high dose)vitamin Kwarfarin underdosage Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium on PT/INR response may be unpredictable.', 'DailyMed'),
(5422, 'levonogestrel and ethinyl estradiol', 'N/A', 'minor', 'These include: Competitive inhibitors for sulfation of ethinyl estradiol in the gastrointestinal wall, such as ascorbic acid (vitamin C) and acetaminophen.', 'DailyMed'),
(5422, 'iron, folate', 'N/A', 'minor', 'Drug Interactions: Davimet™ with Iron Multivitamin Chewable Tablets are not recommended and should not be given to patients receiving levodopa because the action oflevodopa is antagonized by pyridoxine.', 'DailyMed'),
(5422, 'zinc acetate', 'N/A', 'moderate', 'Therefore, precautions for zinc acetate effects do not seem necessary when Wilson’s disease patients are taking vitamin C or approved chelating agents.', 'DailyMed'),
(5422, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(21251, 'sodium chloride', 'N/A', 'moderate', '7.1 Prothrombotic Medical Products Avoid concomitant use of Tranexamic Acid in Sodium Chloride Injection with medical products that are prothrombotic because concomitant use can further increase the risk of thromboembolic adverse reactions associated with tranexamic acid [see Warnings and Precautions (5.1) and Use in Specific Populations (8.3)]. 7.2 Chlorpromazine Concurrent use of chlorpromazine and Tranexamic Acid in Sodium Chloride Injectionmay result in increased risk of bleeding.', 'DailyMed'),
(21251, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Prothrombotic Medical Products: Avoid concomitant use, can further increase the risk of thromboembolic adverse reactions associated with tranexamic acid. (5.1, 7.1, 8.3) 7.1 Prothrombotic Medical Products Avoid concomitant use of Tranexamic Acid Injection with medical products that are prothrombotic because concomitant use can further increase the risk of thromboembolic adverse reactions associated with tranexamic acid [see Warnings and Precautions (5.1), Use in Specific Populations (8.3)].', 'DailyMed'),
(28397, 'sodium chloride', 'N/A', 'moderate', '7.1 Prothrombotic Medical Products Avoid concomitant use of Tranexamic Acid in Sodium Chloride Injection with medical products that are prothrombotic because concomitant use can further increase the risk of thromboembolic adverse reactions associated with tranexamic acid [see Warnings and Precautions (5.1) and Use in Specific Populations (8.3)]. 7.2 Chlorpromazine Concurrent use of chlorpromazine and Tranexamic Acid in Sodium Chloride Injectionmay result in increased risk of bleeding.', 'DailyMed'),
(28397, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Prothrombotic Medical Products: Avoid concomitant use, can further increase the risk of thromboembolic adverse reactions associated with tranexamic acid. (5.1, 7.1, 8.3) 7.1 Prothrombotic Medical Products Avoid concomitant use of Tranexamic Acid Injection with medical products that are prothrombotic because concomitant use can further increase the risk of thromboembolic adverse reactions associated with tranexamic acid [see Warnings and Precautions (5.1), Use in Specific Populations (8.3)].', 'DailyMed'),
(21252, 'sodium chloride', 'N/A', 'moderate', '7.1 Prothrombotic Medical Products Avoid concomitant use of Tranexamic Acid in Sodium Chloride Injection with medical products that are prothrombotic because concomitant use can further increase the risk of thromboembolic adverse reactions associated with tranexamic acid [see Warnings and Precautions (5.1) and Use in Specific Populations (8.3)]. 7.2 Chlorpromazine Concurrent use of chlorpromazine and Tranexamic Acid in Sodium Chloride Injectionmay result in increased risk of bleeding.', 'DailyMed'),
(21252, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Prothrombotic Medical Products: Avoid concomitant use, can further increase the risk of thromboembolic adverse reactions associated with tranexamic acid. (5.1, 7.1, 8.3) 7.1 Prothrombotic Medical Products Avoid concomitant use of Tranexamic Acid Injection with medical products that are prothrombotic because concomitant use can further increase the risk of thromboembolic adverse reactions associated with tranexamic acid [see Warnings and Precautions (5.1), Use in Specific Populations (8.3)].', 'DailyMed'),
(28447, 'sodium chloride', 'N/A', 'moderate', '7.1 Prothrombotic Medical Products Avoid concomitant use of Tranexamic Acid in Sodium Chloride Injection with medical products that are prothrombotic because concomitant use can further increase the risk of thromboembolic adverse reactions associated with tranexamic acid [see Warnings and Precautions (5.1) and Use in Specific Populations (8.3)]. 7.2 Chlorpromazine Concurrent use of chlorpromazine and Tranexamic Acid in Sodium Chloride Injectionmay result in increased risk of bleeding.', 'DailyMed'),
(28447, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Prothrombotic Medical Products: Avoid concomitant use, can further increase the risk of thromboembolic adverse reactions associated with tranexamic acid. (5.1, 7.1, 8.3) 7.1 Prothrombotic Medical Products Avoid concomitant use of Tranexamic Acid Injection with medical products that are prothrombotic because concomitant use can further increase the risk of thromboembolic adverse reactions associated with tranexamic acid [see Warnings and Precautions (5.1), Use in Specific Populations (8.3)].', 'DailyMed'),
(7461, 'sodium chloride', 'N/A', 'moderate', '7.1 Prothrombotic Medical Products Avoid concomitant use of Tranexamic Acid in Sodium Chloride Injection with medical products that are prothrombotic because concomitant use can further increase the risk of thromboembolic adverse reactions associated with tranexamic acid [see Warnings and Precautions (5.1) and Use in Specific Populations (8.3)]. 7.2 Chlorpromazine Concurrent use of chlorpromazine and Tranexamic Acid in Sodium Chloride Injectionmay result in increased risk of bleeding.', 'DailyMed'),
(7461, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Prothrombotic Medical Products: Avoid concomitant use, can further increase the risk of thromboembolic adverse reactions associated with tranexamic acid. (5.1, 7.1, 8.3) 7.1 Prothrombotic Medical Products Avoid concomitant use of Tranexamic Acid Injection with medical products that are prothrombotic because concomitant use can further increase the risk of thromboembolic adverse reactions associated with tranexamic acid [see Warnings and Precautions (5.1), Use in Specific Populations (8.3)].', 'DailyMed'),
(3760, 'sodium chloride', 'N/A', 'moderate', '7.1 Prothrombotic Medical Products Avoid concomitant use of Tranexamic Acid in Sodium Chloride Injection with medical products that are prothrombotic because concomitant use can further increase the risk of thromboembolic adverse reactions associated with tranexamic acid [see Warnings and Precautions (5.1) and Use in Specific Populations (8.3)]. 7.2 Chlorpromazine Concurrent use of chlorpromazine and Tranexamic Acid in Sodium Chloride Injectionmay result in increased risk of bleeding.', 'DailyMed'),
(3760, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Prothrombotic Medical Products: Avoid concomitant use, can further increase the risk of thromboembolic adverse reactions associated with tranexamic acid. (5.1, 7.1, 8.3) 7.1 Prothrombotic Medical Products Avoid concomitant use of Tranexamic Acid Injection with medical products that are prothrombotic because concomitant use can further increase the risk of thromboembolic adverse reactions associated with tranexamic acid [see Warnings and Precautions (5.1), Use in Specific Populations (8.3)].', 'DailyMed'),
(8181, 'sodium chloride', 'N/A', 'moderate', '7.1 Prothrombotic Medical Products Avoid concomitant use of Tranexamic Acid in Sodium Chloride Injection with medical products that are prothrombotic because concomitant use can further increase the risk of thromboembolic adverse reactions associated with tranexamic acid [see Warnings and Precautions (5.1) and Use in Specific Populations (8.3)]. 7.2 Chlorpromazine Concurrent use of chlorpromazine and Tranexamic Acid in Sodium Chloride Injectionmay result in increased risk of bleeding.', 'DailyMed'),
(8181, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Prothrombotic Medical Products: Avoid concomitant use, can further increase the risk of thromboembolic adverse reactions associated with tranexamic acid. (5.1, 7.1, 8.3) 7.1 Prothrombotic Medical Products Avoid concomitant use of Tranexamic Acid Injection with medical products that are prothrombotic because concomitant use can further increase the risk of thromboembolic adverse reactions associated with tranexamic acid [see Warnings and Precautions (5.1), Use in Specific Populations (8.3)].', 'DailyMed'),
(20325, 'sodium chloride', 'N/A', 'moderate', '7.1 Prothrombotic Medical Products Avoid concomitant use of Tranexamic Acid in Sodium Chloride Injection with medical products that are prothrombotic because concomitant use can further increase the risk of thromboembolic adverse reactions associated with tranexamic acid [see Warnings and Precautions (5.1) and Use in Specific Populations (8.3)]. 7.2 Chlorpromazine Concurrent use of chlorpromazine and Tranexamic Acid in Sodium Chloride Injectionmay result in increased risk of bleeding.', 'DailyMed'),
(20325, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Prothrombotic Medical Products: Avoid concomitant use, can further increase the risk of thromboembolic adverse reactions associated with tranexamic acid. (5.1, 7.1, 8.3) 7.1 Prothrombotic Medical Products Avoid concomitant use of Tranexamic Acid Injection with medical products that are prothrombotic because concomitant use can further increase the risk of thromboembolic adverse reactions associated with tranexamic acid [see Warnings and Precautions (5.1), Use in Specific Populations (8.3)].', 'DailyMed'),
(29855, 'sodium chloride', 'N/A', 'moderate', '7.1 Prothrombotic Medical Products Avoid concomitant use of Tranexamic Acid in Sodium Chloride Injection with medical products that are prothrombotic because concomitant use can further increase the risk of thromboembolic adverse reactions associated with tranexamic acid [see Warnings and Precautions (5.1) and Use in Specific Populations (8.3)]. 7.2 Chlorpromazine Concurrent use of chlorpromazine and Tranexamic Acid in Sodium Chloride Injectionmay result in increased risk of bleeding.', 'DailyMed'),
(29855, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Prothrombotic Medical Products: Avoid concomitant use, can further increase the risk of thromboembolic adverse reactions associated with tranexamic acid. (5.1, 7.1, 8.3) 7.1 Prothrombotic Medical Products Avoid concomitant use of Tranexamic Acid Injection with medical products that are prothrombotic because concomitant use can further increase the risk of thromboembolic adverse reactions associated with tranexamic acid [see Warnings and Precautions (5.1), Use in Specific Populations (8.3)].', 'DailyMed'),
(15363, 'sodium chloride', 'N/A', 'moderate', '7.1 Prothrombotic Medical Products Avoid concomitant use of Tranexamic Acid in Sodium Chloride Injection with medical products that are prothrombotic because concomitant use can further increase the risk of thromboembolic adverse reactions associated with tranexamic acid [see Warnings and Precautions (5.1) and Use in Specific Populations (8.3)]. 7.2 Chlorpromazine Concurrent use of chlorpromazine and Tranexamic Acid in Sodium Chloride Injectionmay result in increased risk of bleeding.', 'DailyMed'),
(15363, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Prothrombotic Medical Products: Avoid concomitant use, can further increase the risk of thromboembolic adverse reactions associated with tranexamic acid. (5.1, 7.1, 8.3) 7.1 Prothrombotic Medical Products Avoid concomitant use of Tranexamic Acid Injection with medical products that are prothrombotic because concomitant use can further increase the risk of thromboembolic adverse reactions associated with tranexamic acid [see Warnings and Precautions (5.1), Use in Specific Populations (8.3)].', 'DailyMed'),
(20330, 'sodium chloride', 'N/A', 'moderate', '7.1 Prothrombotic Medical Products Avoid concomitant use of Tranexamic Acid in Sodium Chloride Injection with medical products that are prothrombotic because concomitant use can further increase the risk of thromboembolic adverse reactions associated with tranexamic acid [see Warnings and Precautions (5.1) and Use in Specific Populations (8.3)]. 7.2 Chlorpromazine Concurrent use of chlorpromazine and Tranexamic Acid in Sodium Chloride Injectionmay result in increased risk of bleeding.', 'DailyMed'),
(20330, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Prothrombotic Medical Products: Avoid concomitant use, can further increase the risk of thromboembolic adverse reactions associated with tranexamic acid. (5.1, 7.1, 8.3) 7.1 Prothrombotic Medical Products Avoid concomitant use of Tranexamic Acid Injection with medical products that are prothrombotic because concomitant use can further increase the risk of thromboembolic adverse reactions associated with tranexamic acid [see Warnings and Precautions (5.1), Use in Specific Populations (8.3)].', 'DailyMed'),
(20326, 'sodium chloride', 'N/A', 'moderate', '7.1 Prothrombotic Medical Products Avoid concomitant use of Tranexamic Acid in Sodium Chloride Injection with medical products that are prothrombotic because concomitant use can further increase the risk of thromboembolic adverse reactions associated with tranexamic acid [see Warnings and Precautions (5.1) and Use in Specific Populations (8.3)]. 7.2 Chlorpromazine Concurrent use of chlorpromazine and Tranexamic Acid in Sodium Chloride Injectionmay result in increased risk of bleeding.', 'DailyMed'),
(20326, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Prothrombotic Medical Products: Avoid concomitant use, can further increase the risk of thromboembolic adverse reactions associated with tranexamic acid. (5.1, 7.1, 8.3) 7.1 Prothrombotic Medical Products Avoid concomitant use of Tranexamic Acid Injection with medical products that are prothrombotic because concomitant use can further increase the risk of thromboembolic adverse reactions associated with tranexamic acid [see Warnings and Precautions (5.1), Use in Specific Populations (8.3)].', 'DailyMed'),
(27923, 'sodium chloride', 'N/A', 'moderate', '7.1 Prothrombotic Medical Products Avoid concomitant use of Tranexamic Acid in Sodium Chloride Injection with medical products that are prothrombotic because concomitant use can further increase the risk of thromboembolic adverse reactions associated with tranexamic acid [see Warnings and Precautions (5.1) and Use in Specific Populations (8.3)]. 7.2 Chlorpromazine Concurrent use of chlorpromazine and Tranexamic Acid in Sodium Chloride Injectionmay result in increased risk of bleeding.', 'DailyMed'),
(27923, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Prothrombotic Medical Products: Avoid concomitant use, can further increase the risk of thromboembolic adverse reactions associated with tranexamic acid. (5.1, 7.1, 8.3) 7.1 Prothrombotic Medical Products Avoid concomitant use of Tranexamic Acid Injection with medical products that are prothrombotic because concomitant use can further increase the risk of thromboembolic adverse reactions associated with tranexamic acid [see Warnings and Precautions (5.1), Use in Specific Populations (8.3)].', 'DailyMed'),
(17001, 'sodium chloride', 'N/A', 'moderate', '7.1 Prothrombotic Medical Products Avoid concomitant use of Tranexamic Acid in Sodium Chloride Injection with medical products that are prothrombotic because concomitant use can further increase the risk of thromboembolic adverse reactions associated with tranexamic acid [see Warnings and Precautions (5.1) and Use in Specific Populations (8.3)]. 7.2 Chlorpromazine Concurrent use of chlorpromazine and Tranexamic Acid in Sodium Chloride Injectionmay result in increased risk of bleeding.', 'DailyMed'),
(17001, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Prothrombotic Medical Products: Avoid concomitant use, can further increase the risk of thromboembolic adverse reactions associated with tranexamic acid. (5.1, 7.1, 8.3) 7.1 Prothrombotic Medical Products Avoid concomitant use of Tranexamic Acid Injection with medical products that are prothrombotic because concomitant use can further increase the risk of thromboembolic adverse reactions associated with tranexamic acid [see Warnings and Precautions (5.1), Use in Specific Populations (8.3)].', 'DailyMed'),
(5139, 'sodium chloride', 'N/A', 'moderate', '7.1 Prothrombotic Medical Products Avoid concomitant use of Tranexamic Acid in Sodium Chloride Injection with medical products that are prothrombotic because concomitant use can further increase the risk of thromboembolic adverse reactions associated with tranexamic acid [see Warnings and Precautions (5.1) and Use in Specific Populations (8.3)]. 7.2 Chlorpromazine Concurrent use of chlorpromazine and Tranexamic Acid in Sodium Chloride Injectionmay result in increased risk of bleeding.', 'DailyMed'),
(5139, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Prothrombotic Medical Products: Avoid concomitant use, can further increase the risk of thromboembolic adverse reactions associated with tranexamic acid. (5.1, 7.1, 8.3) 7.1 Prothrombotic Medical Products Avoid concomitant use of Tranexamic Acid Injection with medical products that are prothrombotic because concomitant use can further increase the risk of thromboembolic adverse reactions associated with tranexamic acid [see Warnings and Precautions (5.1), Use in Specific Populations (8.3)].', 'DailyMed'),
(20127, 'sodium chloride', 'N/A', 'moderate', '7.1 Prothrombotic Medical Products Avoid concomitant use of Tranexamic Acid in Sodium Chloride Injection with medical products that are prothrombotic because concomitant use can further increase the risk of thromboembolic adverse reactions associated with tranexamic acid [see Warnings and Precautions (5.1) and Use in Specific Populations (8.3)]. 7.2 Chlorpromazine Concurrent use of chlorpromazine and Tranexamic Acid in Sodium Chloride Injectionmay result in increased risk of bleeding.', 'DailyMed'),
(20127, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Prothrombotic Medical Products: Avoid concomitant use, can further increase the risk of thromboembolic adverse reactions associated with tranexamic acid. (5.1, 7.1, 8.3) 7.1 Prothrombotic Medical Products Avoid concomitant use of Tranexamic Acid Injection with medical products that are prothrombotic because concomitant use can further increase the risk of thromboembolic adverse reactions associated with tranexamic acid [see Warnings and Precautions (5.1), Use in Specific Populations (8.3)].', 'DailyMed'),
(10208, 'sodium chloride', 'N/A', 'moderate', '7.1 Prothrombotic Medical Products Avoid concomitant use of Tranexamic Acid in Sodium Chloride Injection with medical products that are prothrombotic because concomitant use can further increase the risk of thromboembolic adverse reactions associated with tranexamic acid [see Warnings and Precautions (5.1) and Use in Specific Populations (8.3)]. 7.2 Chlorpromazine Concurrent use of chlorpromazine and Tranexamic Acid in Sodium Chloride Injectionmay result in increased risk of bleeding.', 'DailyMed'),
(10208, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Prothrombotic Medical Products: Avoid concomitant use, can further increase the risk of thromboembolic adverse reactions associated with tranexamic acid. (5.1, 7.1, 8.3) 7.1 Prothrombotic Medical Products Avoid concomitant use of Tranexamic Acid Injection with medical products that are prothrombotic because concomitant use can further increase the risk of thromboembolic adverse reactions associated with tranexamic acid [see Warnings and Precautions (5.1), Use in Specific Populations (8.3)].', 'DailyMed'),
(1696, 'sodium chloride', 'N/A', 'moderate', '7.1 Prothrombotic Medical Products Avoid concomitant use of Tranexamic Acid in Sodium Chloride Injection with medical products that are prothrombotic because concomitant use can further increase the risk of thromboembolic adverse reactions associated with tranexamic acid [see Warnings and Precautions (5.1) and Use in Specific Populations (8.3)]. 7.2 Chlorpromazine Concurrent use of chlorpromazine and Tranexamic Acid in Sodium Chloride Injectionmay result in increased risk of bleeding.', 'DailyMed'),
(1696, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Prothrombotic Medical Products: Avoid concomitant use, can further increase the risk of thromboembolic adverse reactions associated with tranexamic acid. (5.1, 7.1, 8.3) 7.1 Prothrombotic Medical Products Avoid concomitant use of Tranexamic Acid Injection with medical products that are prothrombotic because concomitant use can further increase the risk of thromboembolic adverse reactions associated with tranexamic acid [see Warnings and Precautions (5.1), Use in Specific Populations (8.3)].', 'DailyMed'),
(17002, 'sodium chloride', 'N/A', 'moderate', '7.1 Prothrombotic Medical Products Avoid concomitant use of Tranexamic Acid in Sodium Chloride Injection with medical products that are prothrombotic because concomitant use can further increase the risk of thromboembolic adverse reactions associated with tranexamic acid [see Warnings and Precautions (5.1) and Use in Specific Populations (8.3)]. 7.2 Chlorpromazine Concurrent use of chlorpromazine and Tranexamic Acid in Sodium Chloride Injectionmay result in increased risk of bleeding.', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(17002, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Prothrombotic Medical Products: Avoid concomitant use, can further increase the risk of thromboembolic adverse reactions associated with tranexamic acid. (5.1, 7.1, 8.3) 7.1 Prothrombotic Medical Products Avoid concomitant use of Tranexamic Acid Injection with medical products that are prothrombotic because concomitant use can further increase the risk of thromboembolic adverse reactions associated with tranexamic acid [see Warnings and Precautions (5.1), Use in Specific Populations (8.3)].', 'DailyMed'),
(20329, 'sodium chloride', 'N/A', 'moderate', '7.1 Prothrombotic Medical Products Avoid concomitant use of Tranexamic Acid in Sodium Chloride Injection with medical products that are prothrombotic because concomitant use can further increase the risk of thromboembolic adverse reactions associated with tranexamic acid [see Warnings and Precautions (5.1) and Use in Specific Populations (8.3)]. 7.2 Chlorpromazine Concurrent use of chlorpromazine and Tranexamic Acid in Sodium Chloride Injectionmay result in increased risk of bleeding.', 'DailyMed'),
(20329, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Prothrombotic Medical Products: Avoid concomitant use, can further increase the risk of thromboembolic adverse reactions associated with tranexamic acid. (5.1, 7.1, 8.3) 7.1 Prothrombotic Medical Products Avoid concomitant use of Tranexamic Acid Injection with medical products that are prothrombotic because concomitant use can further increase the risk of thromboembolic adverse reactions associated with tranexamic acid [see Warnings and Precautions (5.1), Use in Specific Populations (8.3)].', 'DailyMed'),
(26563, 'sodium chloride', 'N/A', 'moderate', '7.1 Prothrombotic Medical Products Avoid concomitant use of Tranexamic Acid in Sodium Chloride Injection with medical products that are prothrombotic because concomitant use can further increase the risk of thromboembolic adverse reactions associated with tranexamic acid [see Warnings and Precautions (5.1) and Use in Specific Populations (8.3)]. 7.2 Chlorpromazine Concurrent use of chlorpromazine and Tranexamic Acid in Sodium Chloride Injectionmay result in increased risk of bleeding.', 'DailyMed'),
(26563, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Prothrombotic Medical Products: Avoid concomitant use, can further increase the risk of thromboembolic adverse reactions associated with tranexamic acid. (5.1, 7.1, 8.3) 7.1 Prothrombotic Medical Products Avoid concomitant use of Tranexamic Acid Injection with medical products that are prothrombotic because concomitant use can further increase the risk of thromboembolic adverse reactions associated with tranexamic acid [see Warnings and Precautions (5.1), Use in Specific Populations (8.3)].', 'DailyMed'),
(32076, 'sodium chloride', 'N/A', 'moderate', '7.1 Prothrombotic Medical Products Avoid concomitant use of Tranexamic Acid in Sodium Chloride Injection with medical products that are prothrombotic because concomitant use can further increase the risk of thromboembolic adverse reactions associated with tranexamic acid [see Warnings and Precautions (5.1) and Use in Specific Populations (8.3)]. 7.2 Chlorpromazine Concurrent use of chlorpromazine and Tranexamic Acid in Sodium Chloride Injectionmay result in increased risk of bleeding.', 'DailyMed'),
(32076, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Prothrombotic Medical Products: Avoid concomitant use, can further increase the risk of thromboembolic adverse reactions associated with tranexamic acid. (5.1, 7.1, 8.3) 7.1 Prothrombotic Medical Products Avoid concomitant use of Tranexamic Acid Injection with medical products that are prothrombotic because concomitant use can further increase the risk of thromboembolic adverse reactions associated with tranexamic acid [see Warnings and Precautions (5.1), Use in Specific Populations (8.3)].', 'DailyMed'),
(931, 'warfarin sodium', 'N/A', 'minor', 'Acetaminophenalcohol†allopurinolaminosalicylic acidamiodarone HClargatrobanaspirinatenololatorvastatin†azithromycinbivalirudincapecitabinecefamandolecefazolincefoperazonecefotetancefoxitinceftriaxonecelecoxibcerivastatinchenodiolchloramphenicolchloral hydrate†chlorpropamidecholestyramine†cimetidineciprofloxacincisaprideclarithromycinclofibratecyclophosphamide†danazoldextrandextrothyroxinediazoxide diclofenacdicumaroldiflunisaldisulfiramdoxycyclineerythromycinesomeprazoleethacrynic acidezetimibefenofibratefenoprofenfluconazolefluorouracilfluoxetineflutamidefluvastatinfluvoxaminegefitinibgemifibrozilglucagonhalothaneheparinibuprofenifosfamideindomethacininfluenza virus vaccineitraconazoleketoprofenketorolaclansoprazolelepirudinlevamisolelevofloxacinlevothyroxineliothyronine lovastatinmefenam', 'DailyMed'),
(931, 'orlistat', 'N/A', 'minor', 'XENICAL inhibited absorption of a vitamin E acetate supplement.', 'DailyMed'),
(931, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(931, 'selumetinib', 'N/A', 'minor', 'Vitamin E Clinical Impact •KOSELUGO capsules contain vitamin E and daily vitamin E intake that exceeds the recommended or safe limits may increase the risk of bleeding. Management •Supplemental vitamin E is not recommended if daily vitamin E intake (including the amount of vitamin E in KOSELUGO capsules and supplement) will exceed the recommended or safe limits.', 'DailyMed'),
(10206, 'warfarin sodium', 'N/A', 'minor', 'Acetaminophenalcohol†allopurinolaminosalicylic acidamiodarone HClargatrobanaspirinatenololatorvastatin†azithromycinbivalirudincapecitabinecefamandolecefazolincefoperazonecefotetancefoxitinceftriaxonecelecoxibcerivastatinchenodiolchloramphenicolchloral hydrate†chlorpropamidecholestyramine†cimetidineciprofloxacincisaprideclarithromycinclofibratecyclophosphamide†danazoldextrandextrothyroxinediazoxide diclofenacdicumaroldiflunisaldisulfiramdoxycyclineerythromycinesomeprazoleethacrynic acidezetimibefenofibratefenoprofenfluconazolefluorouracilfluoxetineflutamidefluvastatinfluvoxaminegefitinibgemifibrozilglucagonhalothaneheparinibuprofenifosfamideindomethacininfluenza virus vaccineitraconazoleketoprofenketorolaclansoprazolelepirudinlevamisolelevofloxacinlevothyroxineliothyronine lovastatinmefenam', 'DailyMed'),
(10206, 'orlistat', 'N/A', 'minor', 'XENICAL inhibited absorption of a vitamin E acetate supplement.', 'DailyMed'),
(10206, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(10206, 'selumetinib', 'N/A', 'minor', 'Vitamin E Clinical Impact •KOSELUGO capsules contain vitamin E and daily vitamin E intake that exceeds the recommended or safe limits may increase the risk of bleeding. Management •Supplemental vitamin E is not recommended if daily vitamin E intake (including the amount of vitamin E in KOSELUGO capsules and supplement) will exceed the recommended or safe limits.', 'DailyMed'),
(13438, 'orlistat', 'N/A', 'minor', 'XENICAL inhibited absorption of a vitamin E acetate supplement.', 'DailyMed'),
(13438, 'selumetinib', 'N/A', 'minor', 'Vitamin E Clinical Impact •KOSELUGO capsules contain vitamin E and daily vitamin E intake that exceeds the recommended or safe limits may increase the risk of bleeding. Management •Supplemental vitamin E is not recommended if daily vitamin E intake (including the amount of vitamin E in KOSELUGO capsules and supplement) will exceed the recommended or safe limits.', 'DailyMed'),
(18215, 'warfarin sodium', 'N/A', 'minor', 'Acetaminophenalcohol†allopurinolaminosalicylic acidamiodarone HClargatrobanaspirinatenololatorvastatin†azithromycinbivalirudincapecitabinecefamandolecefazolincefoperazonecefotetancefoxitinceftriaxonecelecoxibcerivastatinchenodiolchloramphenicolchloral hydrate†chlorpropamidecholestyramine†cimetidineciprofloxacincisaprideclarithromycinclofibratecyclophosphamide†danazoldextrandextrothyroxinediazoxide diclofenacdicumaroldiflunisaldisulfiramdoxycyclineerythromycinesomeprazoleethacrynic acidezetimibefenofibratefenoprofenfluconazolefluorouracilfluoxetineflutamidefluvastatinfluvoxaminegefitinibgemifibrozilglucagonhalothaneheparinibuprofenifosfamideindomethacininfluenza virus vaccineitraconazoleketoprofenketorolaclansoprazolelepirudinlevamisolelevofloxacinlevothyroxineliothyronine lovastatinmefenam', 'DailyMed'),
(18215, 'orlistat', 'N/A', 'minor', 'XENICAL inhibited absorption of a vitamin E acetate supplement.', 'DailyMed'),
(18215, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(18215, 'selumetinib', 'N/A', 'minor', 'Vitamin E Clinical Impact •KOSELUGO capsules contain vitamin E and daily vitamin E intake that exceeds the recommended or safe limits may increase the risk of bleeding. Management •Supplemental vitamin E is not recommended if daily vitamin E intake (including the amount of vitamin E in KOSELUGO capsules and supplement) will exceed the recommended or safe limits.', 'DailyMed'),
(19287, 'warfarin sodium', 'N/A', 'minor', 'Acetaminophenalcohol†allopurinolaminosalicylic acidamiodarone HClargatrobanaspirinatenololatorvastatin†azithromycinbivalirudincapecitabinecefamandolecefazolincefoperazonecefotetancefoxitinceftriaxonecelecoxibcerivastatinchenodiolchloramphenicolchloral hydrate†chlorpropamidecholestyramine†cimetidineciprofloxacincisaprideclarithromycinclofibratecyclophosphamide†danazoldextrandextrothyroxinediazoxide diclofenacdicumaroldiflunisaldisulfiramdoxycyclineerythromycinesomeprazoleethacrynic acidezetimibefenofibratefenoprofenfluconazolefluorouracilfluoxetineflutamidefluvastatinfluvoxaminegefitinibgemifibrozilglucagonhalothaneheparinibuprofenifosfamideindomethacininfluenza virus vaccineitraconazoleketoprofenketorolaclansoprazolelepirudinlevamisolelevofloxacinlevothyroxineliothyronine lovastatinmefenam', 'DailyMed'),
(19287, 'orlistat', 'N/A', 'minor', 'XENICAL inhibited absorption of a vitamin E acetate supplement.', 'DailyMed'),
(19287, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(19287, 'selumetinib', 'N/A', 'minor', 'Vitamin E Clinical Impact •KOSELUGO capsules contain vitamin E and daily vitamin E intake that exceeds the recommended or safe limits may increase the risk of bleeding. Management •Supplemental vitamin E is not recommended if daily vitamin E intake (including the amount of vitamin E in KOSELUGO capsules and supplement) will exceed the recommended or safe limits.', 'DailyMed'),
(23952, 'orlistat', 'N/A', 'minor', 'XENICAL inhibited absorption of a vitamin E acetate supplement.', 'DailyMed'),
(23952, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(23952, 'selumetinib', 'N/A', 'minor', 'Vitamin E Clinical Impact •KOSELUGO capsules contain vitamin E and daily vitamin E intake that exceeds the recommended or safe limits may increase the risk of bleeding. Management •Supplemental vitamin E is not recommended if daily vitamin E intake (including the amount of vitamin E in KOSELUGO capsules and supplement) will exceed the recommended or safe limits.', 'DailyMed'),
(24944, 'warfarin sodium', 'N/A', 'minor', 'Acetaminophenalcohol†allopurinolaminosalicylic acidamiodarone HClargatrobanaspirinatenololatorvastatin†azithromycinbivalirudincapecitabinecefamandolecefazolincefoperazonecefotetancefoxitinceftriaxonecelecoxibcerivastatinchenodiolchloramphenicolchloral hydrate†chlorpropamidecholestyramine†cimetidineciprofloxacincisaprideclarithromycinclofibratecyclophosphamide†danazoldextrandextrothyroxinediazoxide diclofenacdicumaroldiflunisaldisulfiramdoxycyclineerythromycinesomeprazoleethacrynic acidezetimibefenofibratefenoprofenfluconazolefluorouracilfluoxetineflutamidefluvastatinfluvoxaminegefitinibgemifibrozilglucagonhalothaneheparinibuprofenifosfamideindomethacininfluenza virus vaccineitraconazoleketoprofenketorolaclansoprazolelepirudinlevamisolelevofloxacinlevothyroxineliothyronine lovastatinmefenam', 'DailyMed'),
(24944, 'orlistat', 'N/A', 'minor', 'XENICAL inhibited absorption of a vitamin E acetate supplement.', 'DailyMed'),
(24944, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(24944, 'selumetinib', 'N/A', 'minor', 'Vitamin E Clinical Impact •KOSELUGO capsules contain vitamin E and daily vitamin E intake that exceeds the recommended or safe limits may increase the risk of bleeding. Management •Supplemental vitamin E is not recommended if daily vitamin E intake (including the amount of vitamin E in KOSELUGO capsules and supplement) will exceed the recommended or safe limits.', 'DailyMed'),
(7960, 'warfarin sodium', 'N/A', 'minor', 'Acetaminophenalcohol†allopurinolaminosalicylic acidamiodarone HClargatrobanaspirinatenololatorvastatin†azithromycinbivalirudincapecitabinecefamandolecefazolincefoperazonecefotetancefoxitinceftriaxonecelecoxibcerivastatinchenodiolchloramphenicolchloral hydrate†chlorpropamidecholestyramine†cimetidineciprofloxacincisaprideclarithromycinclofibratecyclophosphamide†danazoldextrandextrothyroxinediazoxide diclofenacdicumaroldiflunisaldisulfiramdoxycyclineerythromycinesomeprazoleethacrynic acidezetimibefenofibratefenoprofenfluconazolefluorouracilfluoxetineflutamidefluvastatinfluvoxaminegefitinibgemifibrozilglucagonhalothaneheparinibuprofenifosfamideindomethacininfluenza virus vaccineitraconazoleketoprofenketorolaclansoprazolelepirudinlevamisolelevofloxacinlevothyroxineliothyronine lovastatinmefenam', 'DailyMed'),
(7960, 'orlistat', 'N/A', 'minor', 'XENICAL inhibited absorption of a vitamin E acetate supplement.', 'DailyMed'),
(7960, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(7960, 'selumetinib', 'N/A', 'minor', 'Vitamin E Clinical Impact •KOSELUGO capsules contain vitamin E and daily vitamin E intake that exceeds the recommended or safe limits may increase the risk of bleeding. Management •Supplemental vitamin E is not recommended if daily vitamin E intake (including the amount of vitamin E in KOSELUGO capsules and supplement) will exceed the recommended or safe limits.', 'DailyMed'),
(18019, 'warfarin sodium', 'N/A', 'minor', 'Acetaminophenalcohol†allopurinolaminosalicylic acidamiodarone HClargatrobanaspirinatenololatorvastatin†azithromycinbivalirudincapecitabinecefamandolecefazolincefoperazonecefotetancefoxitinceftriaxonecelecoxibcerivastatinchenodiolchloramphenicolchloral hydrate†chlorpropamidecholestyramine†cimetidineciprofloxacincisaprideclarithromycinclofibratecyclophosphamide†danazoldextrandextrothyroxinediazoxide diclofenacdicumaroldiflunisaldisulfiramdoxycyclineerythromycinesomeprazoleethacrynic acidezetimibefenofibratefenoprofenfluconazolefluorouracilfluoxetineflutamidefluvastatinfluvoxaminegefitinibgemifibrozilglucagonhalothaneheparinibuprofenifosfamideindomethacininfluenza virus vaccineitraconazoleketoprofenketorolaclansoprazolelepirudinlevamisolelevofloxacinlevothyroxineliothyronine lovastatinmefenam', 'DailyMed'),
(18019, 'orlistat', 'N/A', 'minor', 'XENICAL inhibited absorption of a vitamin E acetate supplement.', 'DailyMed'),
(18019, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(18019, 'selumetinib', 'N/A', 'minor', 'Vitamin E Clinical Impact •KOSELUGO capsules contain vitamin E and daily vitamin E intake that exceeds the recommended or safe limits may increase the risk of bleeding. Management •Supplemental vitamin E is not recommended if daily vitamin E intake (including the amount of vitamin E in KOSELUGO capsules and supplement) will exceed the recommended or safe limits.', 'DailyMed'),
(29477, 'warfarin sodium', 'N/A', 'minor', 'Acetaminophenalcohol†allopurinolaminosalicylic acidamiodarone HClargatrobanaspirinatenololatorvastatin†azithromycinbivalirudincapecitabinecefamandolecefazolincefoperazonecefotetancefoxitinceftriaxonecelecoxibcerivastatinchenodiolchloramphenicolchloral hydrate†chlorpropamidecholestyramine†cimetidineciprofloxacincisaprideclarithromycinclofibratecyclophosphamide†danazoldextrandextrothyroxinediazoxide diclofenacdicumaroldiflunisaldisulfiramdoxycyclineerythromycinesomeprazoleethacrynic acidezetimibefenofibratefenoprofenfluconazolefluorouracilfluoxetineflutamidefluvastatinfluvoxaminegefitinibgemifibrozilglucagonhalothaneheparinibuprofenifosfamideindomethacininfluenza virus vaccineitraconazoleketoprofenketorolaclansoprazolelepirudinlevamisolelevofloxacinlevothyroxineliothyronine lovastatinmefenam', 'DailyMed'),
(29477, 'orlistat', 'N/A', 'minor', 'XENICAL inhibited absorption of a vitamin E acetate supplement.', 'DailyMed'),
(29477, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(29477, 'selumetinib', 'N/A', 'minor', 'Vitamin E Clinical Impact •KOSELUGO capsules contain vitamin E and daily vitamin E intake that exceeds the recommended or safe limits may increase the risk of bleeding. Management •Supplemental vitamin E is not recommended if daily vitamin E intake (including the amount of vitamin E in KOSELUGO capsules and supplement) will exceed the recommended or safe limits.', 'DailyMed'),
(26300, 'warfarin sodium', 'N/A', 'minor', 'Acetaminophenalcohol†allopurinolaminosalicylic acidamiodarone HClargatrobanaspirinatenololatorvastatin†azithromycinbivalirudincapecitabinecefamandolecefazolincefoperazonecefotetancefoxitinceftriaxonecelecoxibcerivastatinchenodiolchloramphenicolchloral hydrate†chlorpropamidecholestyramine†cimetidineciprofloxacincisaprideclarithromycinclofibratecyclophosphamide†danazoldextrandextrothyroxinediazoxide diclofenacdicumaroldiflunisaldisulfiramdoxycyclineerythromycinesomeprazoleethacrynic acidezetimibefenofibratefenoprofenfluconazolefluorouracilfluoxetineflutamidefluvastatinfluvoxaminegefitinibgemifibrozilglucagonhalothaneheparinibuprofenifosfamideindomethacininfluenza virus vaccineitraconazoleketoprofenketorolaclansoprazolelepirudinlevamisolelevofloxacinlevothyroxineliothyronine lovastatinmefenam', 'DailyMed'),
(26300, 'orlistat', 'N/A', 'minor', 'XENICAL inhibited absorption of a vitamin E acetate supplement.', 'DailyMed'),
(26300, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(26300, 'selumetinib', 'N/A', 'minor', 'Vitamin E Clinical Impact •KOSELUGO capsules contain vitamin E and daily vitamin E intake that exceeds the recommended or safe limits may increase the risk of bleeding. Management •Supplemental vitamin E is not recommended if daily vitamin E intake (including the amount of vitamin E in KOSELUGO capsules and supplement) will exceed the recommended or safe limits.', 'DailyMed'),
(26889, 'warfarin sodium', 'N/A', 'minor', 'Acetaminophenalcohol†allopurinolaminosalicylic acidamiodarone HClargatrobanaspirinatenololatorvastatin†azithromycinbivalirudincapecitabinecefamandolecefazolincefoperazonecefotetancefoxitinceftriaxonecelecoxibcerivastatinchenodiolchloramphenicolchloral hydrate†chlorpropamidecholestyramine†cimetidineciprofloxacincisaprideclarithromycinclofibratecyclophosphamide†danazoldextrandextrothyroxinediazoxide diclofenacdicumaroldiflunisaldisulfiramdoxycyclineerythromycinesomeprazoleethacrynic acidezetimibefenofibratefenoprofenfluconazolefluorouracilfluoxetineflutamidefluvastatinfluvoxaminegefitinibgemifibrozilglucagonhalothaneheparinibuprofenifosfamideindomethacininfluenza virus vaccineitraconazoleketoprofenketorolaclansoprazolelepirudinlevamisolelevofloxacinlevothyroxineliothyronine lovastatinmefenam', 'DailyMed'),
(26889, 'orlistat', 'N/A', 'minor', 'XENICAL inhibited absorption of a vitamin E acetate supplement.', 'DailyMed'),
(26889, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(26889, 'selumetinib', 'N/A', 'minor', 'Vitamin E Clinical Impact •KOSELUGO capsules contain vitamin E and daily vitamin E intake that exceeds the recommended or safe limits may increase the risk of bleeding. Management •Supplemental vitamin E is not recommended if daily vitamin E intake (including the amount of vitamin E in KOSELUGO capsules and supplement) will exceed the recommended or safe limits.', 'DailyMed'),
(21224, 'orlistat', 'N/A', 'minor', 'XENICAL inhibited absorption of a vitamin E acetate supplement.', 'DailyMed'),
(21224, 'selumetinib', 'N/A', 'minor', 'Vitamin E Clinical Impact •KOSELUGO capsules contain vitamin E and daily vitamin E intake that exceeds the recommended or safe limits may increase the risk of bleeding. Management •Supplemental vitamin E is not recommended if daily vitamin E intake (including the amount of vitamin E in KOSELUGO capsules and supplement) will exceed the recommended or safe limits.', 'DailyMed'),
(22307, 'warfarin sodium', 'N/A', 'minor', 'Acetaminophenalcohol†allopurinolaminosalicylic acidamiodarone HClargatrobanaspirinatenololatorvastatin†azithromycinbivalirudincapecitabinecefamandolecefazolincefoperazonecefotetancefoxitinceftriaxonecelecoxibcerivastatinchenodiolchloramphenicolchloral hydrate†chlorpropamidecholestyramine†cimetidineciprofloxacincisaprideclarithromycinclofibratecyclophosphamide†danazoldextrandextrothyroxinediazoxide diclofenacdicumaroldiflunisaldisulfiramdoxycyclineerythromycinesomeprazoleethacrynic acidezetimibefenofibratefenoprofenfluconazolefluorouracilfluoxetineflutamidefluvastatinfluvoxaminegefitinibgemifibrozilglucagonhalothaneheparinibuprofenifosfamideindomethacininfluenza virus vaccineitraconazoleketoprofenketorolaclansoprazolelepirudinlevamisolelevofloxacinlevothyroxineliothyronine lovastatinmefenam', 'DailyMed'),
(22307, 'orlistat', 'N/A', 'minor', 'XENICAL inhibited absorption of a vitamin E acetate supplement.', 'DailyMed'),
(22307, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(22307, 'selumetinib', 'N/A', 'minor', 'Vitamin E Clinical Impact •KOSELUGO capsules contain vitamin E and daily vitamin E intake that exceeds the recommended or safe limits may increase the risk of bleeding. Management •Supplemental vitamin E is not recommended if daily vitamin E intake (including the amount of vitamin E in KOSELUGO capsules and supplement) will exceed the recommended or safe limits.', 'DailyMed'),
(29464, 'orlistat', 'N/A', 'minor', 'XENICAL inhibited absorption of a vitamin E acetate supplement.', 'DailyMed'),
(29464, 'selumetinib', 'N/A', 'minor', 'Vitamin E Clinical Impact •KOSELUGO capsules contain vitamin E and daily vitamin E intake that exceeds the recommended or safe limits may increase the risk of bleeding. Management •Supplemental vitamin E is not recommended if daily vitamin E intake (including the amount of vitamin E in KOSELUGO capsules and supplement) will exceed the recommended or safe limits.', 'DailyMed'),
(15792, 'warfarin sodium', 'N/A', 'minor', 'Acetaminophenalcohol†allopurinolaminosalicylic acidamiodarone HClargatrobanaspirinatenololatorvastatin†azithromycinbivalirudincapecitabinecefamandolecefazolincefoperazonecefotetancefoxitinceftriaxonecelecoxibcerivastatinchenodiolchloramphenicolchloral hydrate†chlorpropamidecholestyramine†cimetidineciprofloxacincisaprideclarithromycinclofibratecyclophosphamide†danazoldextrandextrothyroxinediazoxide diclofenacdicumaroldiflunisaldisulfiramdoxycyclineerythromycinesomeprazoleethacrynic acidezetimibefenofibratefenoprofenfluconazolefluorouracilfluoxetineflutamidefluvastatinfluvoxaminegefitinibgemifibrozilglucagonhalothaneheparinibuprofenifosfamideindomethacininfluenza virus vaccineitraconazoleketoprofenketorolaclansoprazolelepirudinlevamisolelevofloxacinlevothyroxineliothyronine lovastatinmefenam', 'DailyMed'),
(15792, 'orlistat', 'N/A', 'minor', 'XENICAL inhibited absorption of a vitamin E acetate supplement.', 'DailyMed'),
(15792, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(15792, 'selumetinib', 'N/A', 'minor', 'Vitamin E Clinical Impact •KOSELUGO capsules contain vitamin E and daily vitamin E intake that exceeds the recommended or safe limits may increase the risk of bleeding. Management •Supplemental vitamin E is not recommended if daily vitamin E intake (including the amount of vitamin E in KOSELUGO capsules and supplement) will exceed the recommended or safe limits.', 'DailyMed'),
(26871, 'warfarin sodium', 'N/A', 'minor', 'Acetaminophenalcohol†allopurinolaminosalicylic acidamiodarone HClargatrobanaspirinatenololatorvastatin†azithromycinbivalirudincapecitabinecefamandolecefazolincefoperazonecefotetancefoxitinceftriaxonecelecoxibcerivastatinchenodiolchloramphenicolchloral hydrate†chlorpropamidecholestyramine†cimetidineciprofloxacincisaprideclarithromycinclofibratecyclophosphamide†danazoldextrandextrothyroxinediazoxide diclofenacdicumaroldiflunisaldisulfiramdoxycyclineerythromycinesomeprazoleethacrynic acidezetimibefenofibratefenoprofenfluconazolefluorouracilfluoxetineflutamidefluvastatinfluvoxaminegefitinibgemifibrozilglucagonhalothaneheparinibuprofenifosfamideindomethacininfluenza virus vaccineitraconazoleketoprofenketorolaclansoprazolelepirudinlevamisolelevofloxacinlevothyroxineliothyronine lovastatinmefenam', 'DailyMed'),
(26871, 'orlistat', 'N/A', 'minor', 'XENICAL inhibited absorption of a vitamin E acetate supplement.', 'DailyMed'),
(26871, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(26871, 'selumetinib', 'N/A', 'minor', 'Vitamin E Clinical Impact •KOSELUGO capsules contain vitamin E and daily vitamin E intake that exceeds the recommended or safe limits may increase the risk of bleeding. Management •Supplemental vitamin E is not recommended if daily vitamin E intake (including the amount of vitamin E in KOSELUGO capsules and supplement) will exceed the recommended or safe limits.', 'DailyMed'),
(32832, 'warfarin sodium', 'N/A', 'minor', 'Acetaminophenalcohol†allopurinolaminosalicylic acidamiodarone HClargatrobanaspirinatenololatorvastatin†azithromycinbivalirudincapecitabinecefamandolecefazolincefoperazonecefotetancefoxitinceftriaxonecelecoxibcerivastatinchenodiolchloramphenicolchloral hydrate†chlorpropamidecholestyramine†cimetidineciprofloxacincisaprideclarithromycinclofibratecyclophosphamide†danazoldextrandextrothyroxinediazoxide diclofenacdicumaroldiflunisaldisulfiramdoxycyclineerythromycinesomeprazoleethacrynic acidezetimibefenofibratefenoprofenfluconazolefluorouracilfluoxetineflutamidefluvastatinfluvoxaminegefitinibgemifibrozilglucagonhalothaneheparinibuprofenifosfamideindomethacininfluenza virus vaccineitraconazoleketoprofenketorolaclansoprazolelepirudinlevamisolelevofloxacinlevothyroxineliothyronine lovastatinmefenam', 'DailyMed'),
(32832, 'orlistat', 'N/A', 'minor', 'XENICAL inhibited absorption of a vitamin E acetate supplement.', 'DailyMed'),
(32832, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(32832, 'selumetinib', 'N/A', 'minor', 'Vitamin E Clinical Impact •KOSELUGO capsules contain vitamin E and daily vitamin E intake that exceeds the recommended or safe limits may increase the risk of bleeding. Management •Supplemental vitamin E is not recommended if daily vitamin E intake (including the amount of vitamin E in KOSELUGO capsules and supplement) will exceed the recommended or safe limits.', 'DailyMed'),
(25653, 'orlistat', 'N/A', 'minor', 'XENICAL inhibited absorption of a vitamin E acetate supplement.', 'DailyMed'),
(25653, 'selumetinib', 'N/A', 'minor', 'Vitamin E Clinical Impact •KOSELUGO capsules contain vitamin E and daily vitamin E intake that exceeds the recommended or safe limits may increase the risk of bleeding. Management •Supplemental vitamin E is not recommended if daily vitamin E intake (including the amount of vitamin E in KOSELUGO capsules and supplement) will exceed the recommended or safe limits.', 'DailyMed'),
(31754, 'warfarin sodium', 'N/A', 'minor', 'Acetaminophenalcohol†allopurinolaminosalicylic acidamiodarone HClargatrobanaspirinatenololatorvastatin†azithromycinbivalirudincapecitabinecefamandolecefazolincefoperazonecefotetancefoxitinceftriaxonecelecoxibcerivastatinchenodiolchloramphenicolchloral hydrate†chlorpropamidecholestyramine†cimetidineciprofloxacincisaprideclarithromycinclofibratecyclophosphamide†danazoldextrandextrothyroxinediazoxide diclofenacdicumaroldiflunisaldisulfiramdoxycyclineerythromycinesomeprazoleethacrynic acidezetimibefenofibratefenoprofenfluconazolefluorouracilfluoxetineflutamidefluvastatinfluvoxaminegefitinibgemifibrozilglucagonhalothaneheparinibuprofenifosfamideindomethacininfluenza virus vaccineitraconazoleketoprofenketorolaclansoprazolelepirudinlevamisolelevofloxacinlevothyroxineliothyronine lovastatinmefenam', 'DailyMed'),
(31754, 'orlistat', 'N/A', 'minor', 'XENICAL inhibited absorption of a vitamin E acetate supplement.', 'DailyMed'),
(31754, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(31754, 'selumetinib', 'N/A', 'minor', 'Vitamin E Clinical Impact •KOSELUGO capsules contain vitamin E and daily vitamin E intake that exceeds the recommended or safe limits may increase the risk of bleeding. Management •Supplemental vitamin E is not recommended if daily vitamin E intake (including the amount of vitamin E in KOSELUGO capsules and supplement) will exceed the recommended or safe limits.', 'DailyMed'),
(33670, 'warfarin sodium', 'N/A', 'minor', 'Acetaminophenalcohol†allopurinolaminosalicylic acidamiodarone HClargatrobanaspirinatenololatorvastatin†azithromycinbivalirudincapecitabinecefamandolecefazolincefoperazonecefotetancefoxitinceftriaxonecelecoxibcerivastatinchenodiolchloramphenicolchloral hydrate†chlorpropamidecholestyramine†cimetidineciprofloxacincisaprideclarithromycinclofibratecyclophosphamide†danazoldextrandextrothyroxinediazoxide diclofenacdicumaroldiflunisaldisulfiramdoxycyclineerythromycinesomeprazoleethacrynic acidezetimibefenofibratefenoprofenfluconazolefluorouracilfluoxetineflutamidefluvastatinfluvoxaminegefitinibgemifibrozilglucagonhalothaneheparinibuprofenifosfamideindomethacininfluenza virus vaccineitraconazoleketoprofenketorolaclansoprazolelepirudinlevamisolelevofloxacinlevothyroxineliothyronine lovastatinmefenam', 'DailyMed'),
(33670, 'orlistat', 'N/A', 'minor', 'XENICAL inhibited absorption of a vitamin E acetate supplement.', 'DailyMed'),
(33670, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(33670, 'selumetinib', 'N/A', 'minor', 'Vitamin E Clinical Impact •KOSELUGO capsules contain vitamin E and daily vitamin E intake that exceeds the recommended or safe limits may increase the risk of bleeding. Management •Supplemental vitamin E is not recommended if daily vitamin E intake (including the amount of vitamin E in KOSELUGO capsules and supplement) will exceed the recommended or safe limits.', 'DailyMed'),
(21996, 'warfarin sodium', 'N/A', 'minor', 'Acetaminophenalcohol†allopurinolaminosalicylic acidamiodarone HClargatrobanaspirinatenololatorvastatin†azithromycinbivalirudincapecitabinecefamandolecefazolincefoperazonecefotetancefoxitinceftriaxonecelecoxibcerivastatinchenodiolchloramphenicolchloral hydrate†chlorpropamidecholestyramine†cimetidineciprofloxacincisaprideclarithromycinclofibratecyclophosphamide†danazoldextrandextrothyroxinediazoxide diclofenacdicumaroldiflunisaldisulfiramdoxycyclineerythromycinesomeprazoleethacrynic acidezetimibefenofibratefenoprofenfluconazolefluorouracilfluoxetineflutamidefluvastatinfluvoxaminegefitinibgemifibrozilglucagonhalothaneheparinibuprofenifosfamideindomethacininfluenza virus vaccineitraconazoleketoprofenketorolaclansoprazolelepirudinlevamisolelevofloxacinlevothyroxineliothyronine lovastatinmefenam', 'DailyMed'),
(21996, 'orlistat', 'N/A', 'minor', 'XENICAL inhibited absorption of a vitamin E acetate supplement.', 'DailyMed'),
(21996, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(21996, 'selumetinib', 'N/A', 'minor', 'Vitamin E Clinical Impact •KOSELUGO capsules contain vitamin E and daily vitamin E intake that exceeds the recommended or safe limits may increase the risk of bleeding. Management •Supplemental vitamin E is not recommended if daily vitamin E intake (including the amount of vitamin E in KOSELUGO capsules and supplement) will exceed the recommended or safe limits.', 'DailyMed'),
(32582, 'warfarin sodium', 'N/A', 'minor', 'Acetaminophenalcohol†allopurinolaminosalicylic acidamiodarone HClargatrobanaspirinatenololatorvastatin†azithromycinbivalirudincapecitabinecefamandolecefazolincefoperazonecefotetancefoxitinceftriaxonecelecoxibcerivastatinchenodiolchloramphenicolchloral hydrate†chlorpropamidecholestyramine†cimetidineciprofloxacincisaprideclarithromycinclofibratecyclophosphamide†danazoldextrandextrothyroxinediazoxide diclofenacdicumaroldiflunisaldisulfiramdoxycyclineerythromycinesomeprazoleethacrynic acidezetimibefenofibratefenoprofenfluconazolefluorouracilfluoxetineflutamidefluvastatinfluvoxaminegefitinibgemifibrozilglucagonhalothaneheparinibuprofenifosfamideindomethacininfluenza virus vaccineitraconazoleketoprofenketorolaclansoprazolelepirudinlevamisolelevofloxacinlevothyroxineliothyronine lovastatinmefenam', 'DailyMed'),
(32582, 'orlistat', 'N/A', 'minor', 'XENICAL inhibited absorption of a vitamin E acetate supplement.', 'DailyMed'),
(32582, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(32582, 'selumetinib', 'N/A', 'minor', 'Vitamin E Clinical Impact •KOSELUGO capsules contain vitamin E and daily vitamin E intake that exceeds the recommended or safe limits may increase the risk of bleeding. Management •Supplemental vitamin E is not recommended if daily vitamin E intake (including the amount of vitamin E in KOSELUGO capsules and supplement) will exceed the recommended or safe limits.', 'DailyMed'),
(29487, 'warfarin sodium', 'N/A', 'minor', 'Acetaminophenalcohol†allopurinolaminosalicylic acidamiodarone HClargatrobanaspirinatenololatorvastatin†azithromycinbivalirudincapecitabinecefamandolecefazolincefoperazonecefotetancefoxitinceftriaxonecelecoxibcerivastatinchenodiolchloramphenicolchloral hydrate†chlorpropamidecholestyramine†cimetidineciprofloxacincisaprideclarithromycinclofibratecyclophosphamide†danazoldextrandextrothyroxinediazoxide diclofenacdicumaroldiflunisaldisulfiramdoxycyclineerythromycinesomeprazoleethacrynic acidezetimibefenofibratefenoprofenfluconazolefluorouracilfluoxetineflutamidefluvastatinfluvoxaminegefitinibgemifibrozilglucagonhalothaneheparinibuprofenifosfamideindomethacininfluenza virus vaccineitraconazoleketoprofenketorolaclansoprazolelepirudinlevamisolelevofloxacinlevothyroxineliothyronine lovastatinmefenam', 'DailyMed'),
(29487, 'orlistat', 'N/A', 'minor', 'XENICAL inhibited absorption of a vitamin E acetate supplement.', 'DailyMed'),
(29487, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(29487, 'selumetinib', 'N/A', 'minor', 'Vitamin E Clinical Impact •KOSELUGO capsules contain vitamin E and daily vitamin E intake that exceeds the recommended or safe limits may increase the risk of bleeding. Management •Supplemental vitamin E is not recommended if daily vitamin E intake (including the amount of vitamin E in KOSELUGO capsules and supplement) will exceed the recommended or safe limits.', 'DailyMed'),
(6205, 'orlistat', 'N/A', 'minor', 'XENICAL inhibited absorption of a vitamin E acetate supplement.', 'DailyMed'),
(6205, 'selumetinib', 'N/A', 'minor', 'Vitamin E Clinical Impact •KOSELUGO capsules contain vitamin E and daily vitamin E intake that exceeds the recommended or safe limits may increase the risk of bleeding. Management •Supplemental vitamin E is not recommended if daily vitamin E intake (including the amount of vitamin E in KOSELUGO capsules and supplement) will exceed the recommended or safe limits.', 'DailyMed'),
(14987, 'warfarin sodium', 'N/A', 'minor', 'Acetaminophenalcohol†allopurinolaminosalicylic acidamiodarone HClargatrobanaspirinatenololatorvastatin†azithromycinbivalirudincapecitabinecefamandolecefazolincefoperazonecefotetancefoxitinceftriaxonecelecoxibcerivastatinchenodiolchloramphenicolchloral hydrate†chlorpropamidecholestyramine†cimetidineciprofloxacincisaprideclarithromycinclofibratecyclophosphamide†danazoldextrandextrothyroxinediazoxide diclofenacdicumaroldiflunisaldisulfiramdoxycyclineerythromycinesomeprazoleethacrynic acidezetimibefenofibratefenoprofenfluconazolefluorouracilfluoxetineflutamidefluvastatinfluvoxaminegefitinibgemifibrozilglucagonhalothaneheparinibuprofenifosfamideindomethacininfluenza virus vaccineitraconazoleketoprofenketorolaclansoprazolelepirudinlevamisolelevofloxacinlevothyroxineliothyronine lovastatinmefenam', 'DailyMed'),
(14987, 'orlistat', 'N/A', 'minor', 'XENICAL inhibited absorption of a vitamin E acetate supplement.', 'DailyMed'),
(14987, 'linezolid', 'N/A', 'minor', 'Antioxidants The potential for drug-drug interactions with linezolid and the antioxidants Vitamin C and Vitamin E was studied in healthy volunteers. On Days 2–9, subjects were given either Vitamin C (1,000 mg/day) or Vitamin E (800 IU/ day). The AUC0–∞ of linezolid increased 2.3% when co-administered with Vitamin C and 10.9% when co-administered with Vitamin E.', 'DailyMed'),
(14987, 'selumetinib', 'N/A', 'minor', 'Vitamin E Clinical Impact •KOSELUGO capsules contain vitamin E and daily vitamin E intake that exceeds the recommended or safe limits may increase the risk of bleeding. Management •Supplemental vitamin E is not recommended if daily vitamin E intake (including the amount of vitamin E in KOSELUGO capsules and supplement) will exceed the recommended or safe limits.', 'DailyMed');

